Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies

• Egile Nagusiak: Murtala Bello Abubakar (Egilea), Dawoud Usman (Egilea), Gaber El-Saber Batiha (Egilea), Natália Cruz-Martins (Egilea), Ibrahim Malami (Egilea), Kasimu Ghandi Ibrahim (Egilea), Bilyaminu Abubakar (Egilea), Muhammad Bashir Bello (Egilea), Aliyu Muhammad (Egilea), Siew Hua Gan (Egilea), Aliyu Ibrahim Dabai (Egilea), M Alblihed (Egilea), Arabinda Ghosh (Egilea), Reem H. Badr (Egilea), Devarajan Thangadurai (Egilea), Mustapha Umar Imam (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The 2019 coronavirus disease (COVID-19) is a potentially fatal multisystemic infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Currently, viable therapeutic options that are cost effective, safe and readily available are desired, but lacking. Nevertheless, the pan...